Stillwell R, Mangar D, Mohamed S A, Markowsky S
Nurse Anesth. 1993 Jun;4(2):80-3.
A case of intraoperative recall and awareness in a patient with sickle cell disease who had received midazolam, 10 mg at induction of anesthesia, is reported. The patient was on opioids which may also have caused tolerance. Although the use of midazolam may have been judged to provide adequate amnesia, this was clearly not the case. Upon analysis of the reasons for recall, we predicted from a two-compartment model that the estimated blood level was 88 ng/mL-1; this level would have provided no amnesia. This case illustrates that recall can occur with the use of midazolam, especially if levels become subtherapeutic, and other measures should be taken to provide adequate anesthesia and amnesia.
报告了一例镰状细胞病患者在麻醉诱导时接受10毫克咪达唑仑后出现术中回忆和知晓的病例。该患者正在使用阿片类药物,这也可能导致了耐受性。尽管使用咪达唑仑可能被认为能提供足够的遗忘作用,但显然并非如此。在分析回忆的原因时,我们根据二室模型预测估计血药浓度为88纳克/毫升;这个浓度不会产生遗忘作用。该病例表明,使用咪达唑仑时可能会发生术中回忆,特别是当血药浓度低于治疗水平时,应采取其他措施以提供足够的麻醉和遗忘作用。